Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
1.490
0.00 (0.00%)
At close: Nov 4, 2024, 4:00 PM
1.500
+0.010 (0.67%)
After-hours: Nov 4, 2024, 7:18 PM EST
Regulus Therapeutics Employees
Regulus Therapeutics had 30 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
30
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,179,667
Market Cap
97.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
FONAR | 561 |
MDxHealth | 300 |
Protalix BioTherapeutics | 208 |
Adicet Bio | 143 |
OptimizeRx | 136 |
BioAtla | 65 |
Assertio Holdings | 53 |
Regencell Bioscience Holdings | 12 |
RGLS News
- 27 days ago - Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - PRNewsWire
- 2 months ago - Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences - PRNewsWire
- 3 months ago - Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates - PRNewsWire
- 3 months ago - Regulus Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference - PRNewsWire
- 4 months ago - Regulus Therapeutics Announces Positive Topline Data from the Third Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) - PRNewsWire
- 5 months ago - Regulus Therapeutics Announces Expected Addition to the Russell 3000® and Russell 2000® Indexes - PRNewsWire
- 6 months ago - Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer - PRNewsWire
- 6 months ago - Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates - PRNewsWire